Industry perspectives: ensuring vaccination of children and adolescents without financial barriers.
Feinberg
Mark B
MB
Merck Vaccines and Infectious Diseases, Merck, Medical Affairs and Policy, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA. mark_feinberg@merck.com
Gordon
Lance
L
D000293:Adolescent; D026683:Advisory Committees; D002648:Child; D002675:Child, Preschool; D016527:Drug Costs / Q000706:statistics & numerical data*; D004345:Drug Industry / Q000191:economics*; D018166:Health Care Reform / Q000191:economics; D006284:Health Plan Implementation / Q000191:economics; D006287:Health Planning Guidelines; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D007223:Infant; D017057:Medically Uninsured / Q000706:statistics & numerical data*; D017149:Private Sector / Q000191:economics*; D017150:Public Sector / Q000191:economics*; D012051:Reimbursement Mechanisms / Q000191:economics; D014481:United States; D014611:Vaccination / Q000191:economics*